Apyx Medical Corp (APYX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 32 transactions totaling $480.1K, demonstrating a bullish sentiment with $26.5K in net insider flow. The most recent transaction on Jan 27, 2026 involved a transaction of 12,000 shares valued at $0.
No significant insider buying has been recorded for APYX in the recent period.
No significant insider selling has been recorded for APYX in the recent period.
Based on recent SEC filings, insider sentiment for APYX is bullish with an Insider Alignment Score of 53/100 and a net flow of $26.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Apyx Medical Corp (APYX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading APYX stock, having executed 32 transactions in the past 90 days. The most active insider is Craig A. Swandal (Executive), who has made 9 transactions totaling $431.6K.
Get notified when executives and directors at APYX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | David Roman Shawn | Chief Operating Officer | Option Exercise | 12,000 | $N/A | $0 | C-Suite |
| Jan 27, 2026 | David Roman Shawn | Chief Operating Officer | Option Exercise | 12,000 | $1.80 | $21.6K | C-Suite |
| Aug 13, 2024 | C. Hill Matthew | Executive | Purchase | 5,336 | $1.13 | $6.0K | |
| Dec 12, 2023 | C. Hill Matthew | Executive | Purchase | 2,500 | $2.19 | $5.5K | |
| Nov 14, 2023 | D. Goodwin Charles II | Executive | Purchase | 50,000 | $1.57 | $78.5K | |
| Jul 12, 2023 | Waldman Lawrence | Executive | Option Exercise | 5,338 | $2.97 | $15.9K | |
| Jun 26, 2023 | Hornsby Todd | Executive | Sale | 15,000 | $7.56 | $113.4K | 10b5-1 |
| Jun 26, 2023 | Hornsby Todd | Executive | Option Exercise | 15,000 | $1.77 | $26.6K | 10b5-1 |
| Jun 26, 2023 | Hornsby Todd | Executive | Option Exercise | 15,000 | $1.77 | $26.6K | 10b5-1 |
| Jun 26, 2023 | Hornsby Todd | Executive | Sale | 15,000 | $7.56 | $113.4K | 10b5-1 |
| Jun 6, 2023 | Geraghty Michael | Executive | Option Exercise | 10,000 | $2.79 | $27.9K | |
| Aug 29, 2022 | D. Goodwin Charles II | Executive | Purchase | 2,000 | $5.93 | $11.9K | |
| Aug 29, 2022 | D. Goodwin Charles II | Executive | Purchase | 9,750 | $5.97 | $58.2K | |
| Jul 11, 2022 | Waldman Lawrence | Executive | Option Exercise | 24,000 | $2.54 | $61.0K | |
| Jul 11, 2022 | Citronowicz Moshe | Executive | Option Exercise | 30,000 | $2.54 | $76.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 18 | $693.7K | 49.1% |
Purchase(P) | 6 | $253.3K | 17.9% |
Sale(S) | 2 | $226.8K | 16.1% |
Exercise (Options)(X) | 4 | $123.8K | 8.8% |
Payment(F) | 1 | $83.4K | 5.9% |
Other(O) | 1 | $31.8K | 2.3% |
Insider activity at Apyx Medical Corp shows mixed signals across all time. While $253.3K in purchases indicates some executive confidence,$226.8K in sales balances the picture, resulting in a modest net flow of $26.5K.9 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Craig A. Swandal, has transacted $431.6K during this period.